Alteration of host defense mechanisms by murine cytomegalovirus infection
- 1 December 1977
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 18 (3), 754-760
- https://doi.org/10.1128/iai.18.3.754-760.1977
Abstract
An animal model of a sublethal infection, utilizing murine cytomegalovirus (MCMV), was developed to determine whether immunological factors could contribute to the establishment of a persistent viral infection. Adult female C3H mice inoculated intraperitoneally with 10(5) plaque-forming units of MCMV developed splenomegaly 5 to 12 days after infection. Virus replicated to peak titers (10(3) to 10(6) plaque-forming units per g of tissue) in liver, spleen, lung, kidney, and salivary gland tissue during the acute phase of the infection (3 to 12 days); it then decreased to undetectable levels in all tissues except salivary gland. Serum interferon was detected as early as 12 h after infection, peaked at 36 h (1,093 U/ml), and was undetectable by 4 days after infection. MCMV-infected animals were hyporeactive to interferon induction with New castle disease virus on days 5 to 9 of the infection. Splenic lymphocyte reactivity to phytohemagglutinin and lipopolysaccharide was normal early during the course of the infection, was suppressed during the acute phase of the infection, and had returned to normal by day 18. These data indicate that several parameters of host defense are transiently suppressed during the course of a MCMV infection. The capacity of cytomegaloviruses to alter host resistance may be one factor that contributes to the establishment of a persistent infection.This publication has 25 references indexed in Scilit:
- Suppressed Response to Interferon Induction in Mice Infected with Encephalomyocarditis Virus, Semliki Forest Virus, Influenza A2 Virus, Herpesvirus hominis Type 2, or Murine CytomegalovirusThe Journal of Infectious Diseases, 1977
- Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.The Journal of Experimental Medicine, 1976
- Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.The Journal of Experimental Medicine, 1976
- Effect of Cytosine Arabinoside and 5-Iodo-2′-Deoxyuridine on a Cytomegalovirus Infection in Newborn MiceAntimicrobial Agents and Chemotherapy, 1976
- Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction.The Journal of Experimental Medicine, 1975
- Suppression of in vitro lymphocyte stimulation in mice bearing primary moloney sarcoma virus-induced tumorsCellular Immunology, 1974
- Tilorone Hydrochloride: an Oral Interferon-Inducing AgentAntimicrobial Agents and Chemotherapy, 1972
- Prevalence and duration of postnatally acquired human cytomegalovirus infectionJournal of Chronic Diseases, 1970
- Latent cytomegalovirus infection in blood donorsBMJ, 1969
- AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINSTransplantation, 1968